Industry Pharmacogenomics Working Group C/O Contreras Legal Strategy LLC

990EZ • Fiscal year 2019 • EIN 83-0847467

Jan 01, 2019 to Dec 31, 2019

Organization Profile I-PWG.ORG

Washington, DC

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2019 filings • 501(c)6 • <$500k nonprofits • Source year 2019

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2019 filings • 501(c)6 • <$500k nonprofits • Source year 2019

41%

Higher net margin than 95% of similar nonprofits.

2019 filings • 501(c)6 • <$500k nonprofits • Source year 2019

No value available

This filing does not contain officer compensation rows.

Source year 2019

33%

Faster asset growth than 86% of similar nonprofits.

2019 filings • 501(c)6 • <$500k nonprofits • Annualized from 2018 to 2019

-24%

Faster revenue growth than 14% of similar nonprofits.

2019 filings • 501(c)6 • <$500k nonprofits • Annualized from 2018 to 2019

Balance Sheet

Liabilities / Assets45th percentile

Assets

$169,373

Up $42,409 (+33%) from 2018

Net Assets

No earlier filing loaded for comparison.

Liabilities

Flat

Flat from 2018

Revenue And Expenses

Liabilities / Revenue45th percentile Net Margin95th percentile

Revenue

Down

$103,985

Down $32,015 (-24%) from 2018

Expenses

$61,576

Up $52,540 (+581%) from 2018

Net Income

Down

$42,409

Down $84,555 (-67%) from 2018

Historical Trend

Balance Sheet Trend

Asset Growth86th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

Highlighted filing

2019

Assets$169,373

Liabilities$0

Net Assets-

Open 2019 Filing

Operations Trend

Revenue Growth14th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

Highlighted filing

2019

Revenue$103,985

Expenses$61,576

Net Income$42,409

Open 2019 Filing

Filing Detail Status

This 2019 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

View Latest Detailed Filing (2024)

Jump To

Filing Snapshot

Filing Period: Jan 1, 2019 to Dec 31, 2019

Mission and Program Overview

Mission

To improve patient care through integration of pharmacogenomics in drug development.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2019 • Form 990EZSummary only. Only limited summary data is available for this year.

Open filing

Assets: $169,373
Liabilities: $0
Net assets: -
Revenue: $103,985
Expenses: $61,576
Net income: $42,409

	Balance Sheet			Operations
Year	Assets	Liabilities	Net Assets	Revenue	Expenses	Net Income
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.	$2.68	$0.00	$2.68	$1.10	$1.04	$0.06
2023Summary only. Only limited summary data is available for this year.	$2.62	$0.00		$1.20	$0.89	$0.31
2022Detailed filing. Detailed filing data is available for this year.	$2.31	$0.00	$2.31	$0.80	$1.15	$0.35
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.	$2.66	$0.00	$2.66	$1.17	$0.86	$0.31
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.	$2.35	$0.00	$2.35	$1.20	$0.54	$0.66
2019Summary only. Only limited summary data is available for this year.	$1.69	$0.00		$1.04	$0.62	$0.42
2018Summary only. Only limited summary data is available for this year.	$1.27	$0.00		$1.36	$0.09	$1.27